Disclaimer:
This blog is for informational purposes only and should not be taken as medical advice. Content is sourced from third parties, and we do not guarantee accuracy or accept any liability for its use. Always consult a qualified healthcare professional for medical guidance.
Leiomyosarcoma (LMS) is a rare, aggressive sarcoma from smooth muscle cells, affecting uterus (50%), GI tract, vessels, extremities. It’s high-grade, with metastasis to lungs/liver. In 2025, ~4,000 US cases, median age 50-60, more in women (uterine).
Symptoms include lump/pain at site, abdominal pain/bleeding (uterine), bowel obstruction (GI), swelling (extremity). Advanced causes fatigue, weight loss, breathlessness. Often asymptomatic early.
Causes include genetic mutations (TP53, RB1), radiation (5-10%), no strong hereditary link. Uterine LMS from fibroids (rare). In 2025, genomic instability is key.
Diagnosis uses imaging (CT/MRI for mass), biopsy for histology (spindle cells), immunohistochemistry (SMA+, desmin+). Staging TNM. In 2025, NGS identifies subtypes.
Surgery (wide resection) is primary. Adjuvant radiation for margins, chemo (doxorubicin, gemcitabine) for advanced. Targeted (trabectedin). In 2025, immunotherapy trials show 20% response.
In 2025, 5-year survival is 50-60% localised, 15% metastatic. Surgery cures 60%. By 2030, targeted/immunotherapy could raise metastatic to 30%.
The information for leiomyosarcoma is sourced from Cleveland Clinic’s “Leiomyosarcoma: Symptoms, Treatment & Prognosis” for prognosis; Cancer Center’s “Leiomyosarcoma: Symptoms, Treatment and Prognosis” for treatment; Cancer Therapy Advisor’s “Leiomyosarcoma | Diagnosis & Disease Information” for diagnosis; WebMD’s “Leiomyosarcoma (Cancer in Muscles): Symptoms, Causes, Treatment” for causes; NCBI’s “Leiomyosarcoma – StatPearls” for overview; AHN’s “Leiomyosarcoma | Diagnosis, FAQs, & Care” for care; NORD’s “Leiomyosarcoma – Symptoms, Causes, Treatment” for symptoms; Macmillan’s “Leiomyosarcoma” for symptoms; Apollo Hospitals’s “Leiomyosarcoma – Causes, Symptoms, Diagnosis, and Treatment” for diagnosis; Mayo Clinic’s “Leiomyosarcoma – Symptoms and causes” for causes.
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
1. Scan at your preferred center.
2. Written report from a specialist radiologist sent via email.
3. Access and download your scan images digitally.
4. Upon request, we can send the report and images to your doctor or hospital.
5. For self-referred patients, there is an additional charge of £30, which includes scan referral and a discussion with a private GP before and after the scan